Flavio Aliberti

  https://medium.com/@flavalib Flavio Aliberti brings with him a 25-year track record in consulting around business intelligence, change management, strategy, M&A transformation, IT and SOX auditing for high regulated domains, like Insurance, Airlines, Trade Associations, Automotive, and Pharma. He holds an MSc in Space Aeronautic Engineering from the University of Naples and an MSc in Advanced Information Technology and Business Management from the University of Wales.

 



105 Stories by Flavio Aliberti

BeeHive AI: the future of Life Sciences Supply Chain

Explore how Conversational AI is revolutionizing the Life Sciences supply chain, drawing unique parallels with a thriving beehive’s collective intelligence Imagine a vibrant bee...
0 5 min read 385

Mastering Your Business Sky: The Power of Supply Planning Control Towers

Chart a new course in business strategy: Harness the prowess of air traffic control to pilot enterprises toward unmatched success with Supply Planning Control Towers...
0 3 min read 390

Checkmate or Stalemate? The Global Healthcare M&A Chess Game

Navigate the critical balance of M&A, affordability, and alternative funding pathways shaping our global healthcare’s future Imagine a global chess match, where each move...
0 1 min read 404

The Unspoken Truth About Going Digital in Life Sciences

Discover the human capital’s role, the strategic interventions sequence, and the right partnership’s importance in achieving digital success in life sciences Imagine a doctor examining...
0 7 min read 311

Pharma 2023: Navigating the Revolution of Integrated Supply Chains

Uncover the 2023 life science transformation towards an integrated supply chain, its potential, and challenges Pharmaceuticals are on the cusp of a revolution. The...
0 1 min read 255

Mastering Demand Planning for Big Pharma’s Future

Revolutionizing Supply Chain Efficiency: Unleashing the Power of Demand Planning, Technology, and Clinical Trials in the Pharmaceutical Industry The high-stakes world of pharmaceuticals isn’t...
0 3 min read 308

Drug Repurposing for Faster, Greener, and Affordable Treatments

Unlock drug repurposing potential: 10 facts on orphan drug acceleration & cost reduction in new treatments Imagine a world where we can tap into...
0 11 min read 378

Optimizing the Life Sciences Supply Chain through Network Visibility and Demand-Driven Planning

Explore life sciences supply chain optimization through network visibility, demand-driven planning, digital transformation, and coopetition Introduction: Embracing Digital Transformation and Coopetition The life sciences...
0 3 min read 430

5 Risks in Life Science M&A Transactions: Mitigation Strategies

Are you prepared to mitigate the top 5 risks in life science M&A transactions? Learn how now The life science business is continually developing and...
0 3 min read 329

Will United States of Care change the American healthcare system?

An in-depth look to approaches, challenges, and potential global influence to build a more inclusive society The American healthcare system has long been a...
0 4 min read 317

From Consumer Health to Cutting-Edge Therapies: The Decade in Review

M&A life science transactions can reveal trends and evolutionary patterns in the industry, and can lead to a new ecosystem The integration success between...
0 11 min read 291

Virtual Reality Therapy for Brain-Powered Healing

Explore how research on placebo and virtual reality will transforming healthcare and natural healing For decades, clinical researchers have been fascinated by the placebo effect....
0 3 min read 389